Foreign Bonds, Fres...
Health Care: Health Services
Harvard Bioscience Inc. (HBIO: NASDAQ)
$5.10 -0.08 | -1.54%
05/21/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 20.68M | 17.92M | 19.70M | 16.59M |
| Receivables | 18.98M | 17.58M | 17.59M | 16.63M |
| Inventories | 17.76M | 18.16M | 15.83M | 14.41M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 58.97M | 57.56M | 58.57M | 48.20M |
| Property, Plant & Equipment, Gross | 17.86M | 13.38M | 13.16M | 12.70M |
| Accumulated Depreciation & Depletion | 13.31M | 10.30M | 10.01M | 9.16M |
| Property, Plant & Equipment, Net | 4.55M | 3.09M | 3.15M | 3.54M |
| Intangibles | 22.50M | 23.64M | 23.18M | 22.40M |
| Other Non-Current Assets | 490.00K | 215.00K | 360.00K | 656.00K |
| Total Non-Current Assets | 74.51M | 69.07M | 66.23M | 59.03M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 133.48M | 126.63M | 124.80M | 107.23M |
| Accounts Payable | 4.68M | 4.96M | 4.92M | 4.86M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 1.23M | 794.00K | 1.23M | 3.28M |
| Total Current Liabilities | 9.90M | 9.56M | 11.30M | 12.26M |
| Long Term Debt | 12.95M | 16.30M | 18.01M | 13.31M |
| Deferred Income Taxes | 277.00K | 369.00K | 954.00K | 2.04M |
| Other Non-Current Liabilities | 6.14M | 4.91M | 4.29M | 4.37M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 19.37M | 21.58M | 23.25M | 19.72M |
| Total Liabilities | 29.27M | 31.14M | 34.55M | 31.97M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 104.21M | 95.50M | 90.25M | 75.26M |
| Common Par | 370.00K | 362.00K | 361.00K | 360.00K |
| Additional Paid In Capital | 196.63M | 191.16M | 187.89M | 184.86M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -77.26M | -79.63M | -83.44M | -102.46M |
| Treasury Stock | -10.67M | -10.67M | -10.67M | -5.67M |
| Other Equity Adjustments | -4.86M | -5.72M | -3.90M | -1.83M |
| Total Capitalization | 117.16M | 111.80M | 108.26M | 88.56M |
| Total Equity | 104.21M | 95.50M | 90.25M | 75.26M |
| Total Liabilities & Stock Equity | 133.48M | 126.63M | 124.80M | 107.23M |
| Total Common Shares Outstanding | 29.38M | 28.54M | 28.31M | 29.58M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 7.75M | 7.75M | 7.75M | 6.36M |
| Basic Weighted Shares Outstanding | 28.80M | 28.45M | 28.97M | 29.65M |
| Diluted Weighted Shares Outstanding | 29.42M | 29.82M | 29.40M | 29.95M |
| Number of Employees | 398 | 375 | 368 | 331 |
| Number of Part-Time Employees | 24 | 21 | 21 | 17 |
Portfolios with HBIO
- Portfolio NameUser Type
- UserJoePa66
- Contributor5 Stocks Under-$10 Setting ...
- ContributorTheStreet Ratings Top-Rated...
- UserMike's Safe Play Portfolio
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- Userjim c's Portfolio 1
- UserRocket Stocks For The Week ...
- UserTom's Stuff
Latest HBIO Headlines from TheStreet
- Harvard Bioscience Announces Retirement Of CEO And Appointment Of Interim CEO 05.15.13 | 07:05 am
- HBIO Reports First Quarter 2013 Results 05.02.13 | 07:05 am
- HBIO Affirms Plan To Spin-Off Harvard Apparatus Regenerative Technology, Inc. And Announces Its Intended Path Forward 05.01.13 | 05:05 pm
- Webcast Now Available Of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold And "InBreath" Bioreactor 04.30.13 | 07:04 pm
- Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold And Bioreactor Used In First U.S. Transplant Of A Regenerated Trachea 04.30.13 | 11:04 am
- Harvard Bioscience To Participate In Press Conference Today To Discuss Landmark Surgery 04.30.13 | 07:04 am
- Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call For May 2, 2013 04.26.13 | 02:04 pm
- The Five Dumbest Things on Wall Street: April 12
04.12.13 | 05:04 am - HBIO Announces Postponement Of The IPO For Harvard Apparatus Regenerative Technology, Inc. 04.09.13 | 05:04 pm
- HBIO Announces Filing Of Request For Acceleration Of Effectiveness For Harvard Apparatus Regenerative Technology, Inc.'s IPO Registration Statement 04.02.13 | 07:04 am
Press Releases for HBIO
- SeeThruEquity Launches First Free Institutional Equity Research Platform - Business Wire 06.23.11 | 10:06 am
- Cellectis Grants Harvard Bioscience A License To CytoPulse Electroporation Instruments - PR Newswire 12.02.10 | 02:12 am
Partner Headlines for HBIO
- Investment Potential In Electroporation Companies - Seeking Alpha 07.17.12 | 09:07 am
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- 5 Likely Additions to the Russell 2000 - Seeking Alpha 05.04.11 | 08:05 am
